Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:18 PM
Ignite Modification Date:
2025-12-24 @ 10:18 PM
NCT ID:
NCT02553135
Eligibility Criteria:
Inclusion Criteria:
* 18 Years and older
* Male
* Able to give informed consent
* Genetically confirmed diagnosis of choroideremia
* Active disease visible clinically within the macula region
* Best-corrected visual acuity equal to or worse than 20/32 but better than or equal to 20/200 in the study eye.
Exclusion Criteria:
* Female
* Under the age of 18
* History of amblyopia in the study eye
* Men unwilling to use barrier contraception methods
* Relevant grossly asymmetrical disease or other ocular morbidity which might confound use of the fellow eye as a long-term control
* Any other significant ocular and non-ocular disease/disorder or retinal surgery
* Contraindication to use of medications or contrast agents
* Participated in research study involving an investigational product in the past 12 weeks
* Having had gene or cellular therapy at any time prior to this study.
Healthy Volunteers:
False
Sex:
MALE
Minimum Age:
18 Years
Study:
NCT02553135
Study Brief:
Protocol Section:
NCT02553135